Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation.

@article{Sarwal2003ContinuedSO,
  title={Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation.},
  author={Minnie M. Sarwal and Jayakumar R. Vidhun and Steven R. Alexander and Thomas Satterwhite and Mar{\'i}a Mill{\'a}n and Oscar Salvatierra},
  journal={Transplantation},
  year={2003},
  volume={76 9},
  pages={1331-9}
}
BACKGROUND Corticosteroids have been invariant transplant immunosuppressives with numerous adverse effects. We previously reported 6-month results in 10 patients using extended daclizumab induction to safely eliminate steroid use in pediatric renal transplantation. This expanded pilot series discusses immunosuppression dosing modification to further minimize drug toxicity without sacrificing regimen efficacy. METHODS Fifty-seven pediatric renal transplant recipients were enrolled in the pilot… CONTINUE READING